跳至主要内容
临床试验/EUCTR2008-002681-63-GB
EUCTR2008-002681-63-GB进行中(未招募)1 期

DOES VITAMIN D REDUCE BLOOD PRESSURE AND LV MASS IN RESISTANT HYPERTENSIVE PATIENTS WITH VITAMIN D INSUFFICIENCY? - Vitamin D for resistant hypertension

Research and Innovation Services, University of Dundee0 个研究点目标入组 74 人开始时间: 2008年7月16日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age >18 yrs
  • Office BP >140/90 mmHg despite 3 or more antihypertensive agents
  • Serum 25 Hydroxy vitamin D <75nmol/L
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Hypertension known to be due to a correctable underlying medical or surgical cause
  • Estimated glomerular filtration rate <40mls/min (by 4 variable MDRD equation)
  • Liver function tests (ALT, Bilirubin, Alkaline phosphatase) >3x normal.
  • Corrected calcium >2.60 mmol/L or <2.15 mmol/L
  • Known metastatic malignancy or sarcoidosis
  • Clinical diagnosis of osteomalacia
  • History of renal calculi
  • Diagnosis of heart failure with left ventricular systolic dysfunction
  • Atrial fibrillation
  • Already taking vitamin D supplements (cod liver oil will be permitted however)
  • Unable to give written informed consent
  • Premenopausal / able to bear children (if female)
  • Contraindications to MRI scanning (severe claustrophobia, pacemaker, metal heart valve, metal in eye, ferromagenetic joint implants or spinal rods, implanted nerve stimulator, middle ear implant)

研究者

发起方
Research and Innovation Services, University of Dundee

相似试验